Abstract
The cardiovascular morbidity and mortality are increased in rheumatoid arthritis and probably equal those of patients with type 2 diabetes mellitus. The European League Against Rheumatism has recently provided evidence-based guidelines for cardiovascular risk management in patients with rheumatoid arthritis and we here briefly summarise these guidelines and other recent data in this area of research.
| Bidragets oversatte titel | [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis] |
|---|---|
| Originalsprog | Dansk |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 173 |
| Udgave nummer | 5 |
| Sider (fra-til) | 343-6 |
| Antal sider | 4 |
| Status | Udgivet - 31 jan. 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Overdødelighed af hjerte-kar-sygdomme ved reumatoid artritis'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS